The shots, designed to provide improved protection against omicron subvariants now circulating, are manufactured by Moderna and by Pfizer and its German partner, BioNTech. They were cleared Monday by the Food and Drug Administration and are expected to be reviewed Tuesday by the Centers for Disease Control and Prevention and its advisers.
That means the injections will be available to consumers shortly. Here is what you need to know:…
No comments:
Post a Comment